CORRECTION – Global Reach for Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
24 mars 2025 21h51 HE
|
Avance Clinical
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
CARBOGEN AMCIS opnår GMP-certificering efter vellykket ANSM-inspektion af deres aseptiske produktionssted for lægemidler
24 mars 2025 09h32 HE
|
CARBOGEN AMCIS INNOVATIONS AG
BUBENDORF, Schweiz, March 24, 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS med hjemsted i Schweiz, en førende virksomhed inden for udvikling af farmaceutiske processer og fremstilling af aktive...
CARBOGEN AMCIS erhält GMP-Zertifizierung nach erfolgreicher ANSM-Inspektion für seine Produktionsstätte für aseptische Arzneimittel
24 mars 2025 09h32 HE
|
CARBOGEN AMCIS INNOVATIONS AG
BUBENDORF, Schweiz, March 24, 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS mit Sitz in der Schweiz, ein führendes Unternehmen für pharmazeutische Prozessentwicklung und Wirkstoffherstellung (API), freut...
Après une inspection réussie de l’ANSM, CARBOGEN AMCIS obtient la certification BPF pour son site de fabrication de produits pharmaceutiques aseptiques
24 mars 2025 09h32 HE
|
CARBOGEN AMCIS INNOVATIONS AG
BUBENDORF, Suisse, 24 mars 2025 (GLOBE NEWSWIRE) -- CARBOGEN AMCIS, société suisse leader dans le développement de procédés pharmaceutiques et la fabrication d’ingrédients pharmaceutiques actifs...
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
24 mars 2025 09h32 HE
|
CARBOGEN AMCIS INNOVATIONS AG
CARBOGEN AMCIS has been granted a GMP certificate for the Saint-Beauzire facility, marking a significant milestone in the site's successful start-up.
Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
20 mars 2025 16h05 HE
|
Assembly Biosciences, Inc.
– Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline – – Interim Phase 1b proof-of-concept data, including initial...
Master Biotech Basics: Non-Biotechnologist Training Course Covers Regulations, Patents & Innovations - Join the CPD-Certified Online Training Course on 9-11 July 2025
20 mars 2025 12h30 HE
|
Research and Markets
Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Biotechnology for the Non-Biotechnologist Training Course (ONLINE EVENT: July 9-11, 2025)" has been added to ResearchAndMarkets.com's offering. The...
Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
20 mars 2025 07h30 HE
|
Cytokinetics, Incorporated
Interactive Tool Harnesses Real-World Data to Visualize Burden of Disease in HCM and Advance Equitable Access to Care SOUTH SAN FRANCISCO, Calif., March 20, 2025 (GLOBE NEWSWIRE) --...
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219
20 mars 2025 07h00 HE
|
Sitryx Therapeutics
Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease...
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements
19 mars 2025 07h00 HE
|
Ampersand Biomedicines
$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in immuno-inflammation and immuno-oncology planned to enter...